典型文献
Transient positive antimitochondrial M2 in sera of patients with connective tissue diseases after intravenous immunoglobulin infusions
文献摘要：
Background::Although antinuclear antibodies (ANAs), anti-SSA and anti-Ro52, are present in immunoglobulin preparations, it is unknown whether intravenous immunoglobulin (IVIG) therapy influences the testing of serum autoantibodies in patients with connective tissue diseases (CTDs). The present study aimed to investigate the dynamic change over time of serum ANA-related autoantibodies in patients with CTDs receiving IVIG therapy.Methods::Serum ANA-related autoantibodies were monitored in two patients with CTD before IVIG therapy and at different times after therapy. These autoantibodies were tested in different batches of immunoglobulin preparations from seven pharmaceutical companies.Results::One patient developed a new ANA pattern (cytoplasmic dense fine speckled pattern, AC-19) just after IVIG therapy. Both patients developed de novo positivity for AMA-M2 and anti-SSA, but returned negative 1 month after IVIG therapy. The residual liquid in patients' immunoglobulin preparations showed positive ANAs with a high titer of AC-19 (1:640), a low titer of the nuclear fine speckled pattern (AC-4, 1:80), positive AMA-M2, and positive anti-SSA. ANA-related autoantibodies were tested in 16 batches of immunoglobulin preparations and all had positive ANAs with two patterns: AC-19 (1:640 or 1:320) and AC-4 (1:80). AMA-M2 and anti-SSA were positive in 100% of the batches.Conclusion::Our study highlights high-titer AMA-M2 autoantibodies in immunoglobulin preparations and suggests their transient transfer into a patient's circulation via IVIG therapy. To avoid incorrect clinical decisions based on postinfusion antibody titers, our data recommend retesting 1-2 months after high-dose IVIG immunomodulatory treatment.
文献关键词：
antimitochondrial M2;antinuclear antibodies;connective tissue disease;intravenous immunoglobulins
中图分类号：
作者姓名：
Yang Lijuan;Wei Xiuning;Li Qianhua;Li Honggui;Ouyang Zhiming;Zeng Aiqi;Zheng Donghui;Dai Lie;Mo Yingqian
作者机构：
Department of Rheumatology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China
文献出处：
引用格式：
[1]Yang Lijuan;Wei Xiuning;Li Qianhua;Li Honggui;Ouyang Zhiming;Zeng Aiqi;Zheng Donghui;Dai Lie;Mo Yingqian-.Transient positive antimitochondrial M2 in sera of patients with connective tissue diseases after intravenous immunoglobulin infusions)[J].风湿病与自身免疫（英文）,2022(04):230-236
A类：
antimitochondrial,CTDs,speckled,postinfusion,retesting
B类：
Transient,positive,M2,sera,patients,connective,tissue,diseases,after,intravenous,infusions,Background,Although,antinuclear,ANAs,SSA,Ro52,are,present,preparations,unknown,whether,IVIG,therapy,influences,serum,autoantibodies,study,aimed,investigate,dynamic,change,over,related,receiving,Methods,Serum,were,monitored,two,before,different,times,These,tested,batches,from,seven,pharmaceutical,companies,Results,One,developed,new,cytoplasmic,dense,fine,AC,just,Both,novo,positivity,AMA,but,returned,negative,residual,liquid,showed,low,all,had,patterns,Conclusion,Our,highlights,suggests,their,transient,transfer,into,circulation,via,To,avoid,incorrect,clinical,decisions,antibody,titers,our,data,recommend,months,dose,immunomodulatory,treatment,immunoglobulins
AB值：
0.404074
相似文献
机标中图分类号，由域田数据科技根据网络公开资料自动分析生成，仅供学习研究参考。
